Released on: September 12, 2008, 8:36 am

Press Release Author: AnaSpec Inc.

Industry: Biotech

Press Release Summary: AnaSpec and Cyclex Co. Ltd. today announced a licensing
agreement that will allow AnaSpec to make, use, and sell deacetylase activity assay
kits and the related products as covered by Cyclex’s patent # ‘s EP 1243658, US
7033778, US 7256013.

Press Release Body: September 12, 2008 - San Jose, CA

AnaSpec and Cyclex Co. Ltd. today announced a licensing agreement that will allow
AnaSpec to make, use, and sell deacetylase activity assay kits and the related
products as covered by Cyclex’s patent # ‘s EP 1243658, US 7033778, US 7256013.

"We are pleased to partner with Cyclex in expanding our array of next generation
assay kits," noted Dr. Anita Hong, AnaSpec's president. "The new SensoLyte™ HDAC
assay kits will provide our customers with new long wavelength options for the
detection of histone deacetylase activity. AnaSpec also plans to develop other long
wavelength HDAC related kits including SIRT assay kits."

About AnaSpec

AnaSpec, Inc. is a leading provider of integrated proteomics solutions™ for
worldwide life science research. With a vision for innovation through synergy,
AnaSpec offers expertise in three primary technologies: peptides, detection
reagents, and combinatorial chemistry.

Visit www.anaspec.com for more information

About Cyclex Co. Ltd.

Cyclex Co. Ltd., based in Japan, focuses on the development of drug screening
systems, the development of research use products (Kit, Antibody, Enzyme etc.), and
research for novel genes for drug discovery.

Visit www.cyclex.co.jp for more information.

###




Web Site: http://www.anaspec.com

Contact Details: AnaSpec Inc.
2149 O'Toole Ave.
San Jose, CA 95131
1-408-452-5055 (Tel)
1-408-452-5059 (Fax)
1-800-452-5530
ping@anaspec.com
www.anaspec.com